TrialBritish journal of clinical pharmacology2005

Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients.

J Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.